Tokyo, Dec. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059831) titled 'The effect of transcranial static magnetic field stimulation (tSMS) on sustained attention' on Dec. 15.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Single blind -participants are blinded
Control - Placebo
Primary Sponsor:
Institute - Niigata University of Health and Welfare
Condition:
Condition - healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the neuromodulatory effects induced by tSMS on sustained attention.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - tSMS
Interventions/Control_2 - sham stimulation
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - healthy adults
Key exclusion criteria - pregnant
dialysis patient
taking neuromodulatory medication
presence of a MRI-incompatible metal or electric implant
history of neurological or psychiatric disorder
severe skin lesion
any other individuals deemed unsuitable for the study by the investigators
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 11 Month 17 Day
Anticipated trial start date - 2025 Year 12 Month 20 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068419
Disclaimer: Curated by HT Syndication.
